Fox News medical contributor Dr. Marc Siegel provides insight into the next wave of the coronavirus pandemic and lockdowns.
Ticketmaster may require people to either get the coronavirus vaccine or a negative test before going into concert and sports venues. FOX Business' Kristina Partsinevelos with more.
Stanford University computer science professor Jure Leskovec provides insight into a new study revealing coronavirus hotspots and strategies for limiting the spread.
Buoy Health co-founder and CEO Dr. Andrew Le discusses how his company is changing telemedicine.
Fox News medical contributor Dr. Nicole Saphier weighs in on coronavirus in the U.S. and globally, arguing that individual responsibility is important for overcoming the virus and returning our economy back to normal.
Johns Hopkins School of Public Health Professor Dr. Marty Makary discusses the spike in coronavirus cases and when the population will hit immunity levels.
Duke University Margolis Center for Health Policy Director Dr. Mark McClellan provides insight into the Eli Lilly coronavirus antibody treatment and Pfizer’s vaccine.
GeoVax Chairman, CEO and President David Dodd weighs in on Geovax’s COVID-19 vaccine trials.
Cleveland Clinic Weston Chief Medical Officer Dr. Fabio Potenti weighs in on the COVID-19 vaccine, arguing it’s ‘premature’ for health care professionals to make vaccine recommendations.
Villere & Co. partner and portfolio manager Sandy Villere shares his stock picks in the health and entertainment industries.
New Jersey is now the largest state on the East Coast to go through the legalization process of marijuana. What does this mean for future of the cannabis industry? FOX Business' Kristina Partsinevelos with more.
Eli Lilly's Bamlanivimab will be used for?mild-to-moderate COVID-19 cases in adults who are high-risk, including those 65 years of age or older, or who have certain chronic medical conditions,?and children who are 12 years or older and weight at least 88 pounds.?
Business Insider columnist Adam Lashinsky discusses his outlook for the markets after breakthroughs on a coronavirus vaccine were announced.
Money Map Press chief strategist Shah Gilani and Gibbs Wealth Management president Erin Gibbs provide insight into how to adjust stock market portfolios amid the Pfizer coronavirus vaccine announcement.
Fox News medical contributor Dr. Marc Siegel provides insight into new coronavirus vaccine breakthroughs.
Former Health and Human Services Secretary Dr. Tom Price shares his thoughts on how Joe Biden would handle the coronavirus pandemic and the recent surge in cases.
RBC managing director Mark Mahaney discusses the stock market surging amid coronavirus vaccine talk, saying top stocks in the travel industry are ‘vaccine derivatives.’
Congresswomen Debbie Dingell, D-Mich., and Debbie Lesko, R-Ariz., share their thoughts on voting irregularities in the presidential election, Nancy Pelosi as Speaker of the House and a potential coronavirus vaccine.
Fox News medical contributor Dr. Marc Siegel provides insight into Pfizer’s coronavirus vaccine and vaccine distribution.
Trump 2020 presidential campaign senior adviser Jason Miller on integrity in the 2020 election and the latest headlines surrounding the coronavirus vaccine.